Juno investors eke out $24M settlement in lawsuit over CAR-T trial deaths

 Juno Therapeutics shares took a big hit in 2016 when patients died in a clinical trial testing its groundbreaking CAR-T therapy, known as JCAR015. Investors weren't happy—and some of them sued, claiming the company and its executives had dragged their feet on breaking the bad news.